(Lys9)GLP-1 possesses DPP IV resistance and cellular and metabolic actions similar to those of established antagonists GLP-1(9-36)amide and exendin(9-39).

Autoria(s): O'Harte, F.P.M.; Green, Brian; Mooney, Mark; Gault, V.A.; Irwin, N.; Harriott, Patrick; Greer, B.; Flatt, P.R.
Data(s)

2003
Identificador

http://pure.qub.ac.uk/portal/en/publications/lys9glp1-possesses-dpp-iv-resistance-and-cellular-and-metabolic-actions-similar-to-those-of-established-antagonists-glp1936amide-and-exendin939(7d4d1d1c-b33d-4ca3-947c-7c99f6c4aacb).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

O'Harte , F P M , Green , B , Mooney , M , Gault , V A , Irwin , N , Harriott , P , Greer , B & Flatt , P R 2003 , ' (Lys9)GLP-1 possesses DPP IV resistance and cellular and metabolic actions similar to those of established antagonists GLP-1(9-36)amide and exendin(9-39). ' Irish Journal of Medical Science , vol 172 , no. S1 , pp. P10 .
Tipo

article
Acesso ao item digital